University of Cambridge > Talks.cam > Cambridge Oncology Seminar Series > Using Bayesian analysis in randomised phase II clinical trials to determine the worth of proceeding to phase III

  Browse A-Z

Log in

Googledetails Microsoftdetails

🔐 Log In

Information on

Subscribing to talksdetails Finding a talkdetails Adding a talkdetails Disseminating talksdetails Help and Documentationdetails

ℹī¸ Information

Using Bayesian analysis in randomised phase II clinical trials to determine the worth of proceeding to phase III

Download to your calendar using vCal

If you have a question about this talk, please contact Laura Blackburn .

Abstract not available

This talk is part of the Cambridge Oncology Seminar Series series.

This talk is included in these lists:

Note that ex-directory lists are not shown.

Other lists

Makespace Cambridge, 16 Mill Lane, CB2 1RX Kaetsu Centre, Murray Edwards College Department of Pharmacology Seminar Room

Other talks

Talk title TBC Pancreatic cancer - the clinical challenge;  Why the microenvironment matters during pancreatic cancer progression and treatment Differences between Robin and Neumann eigenvalues John Kendrew Lecture - Title TBC Christopher Cowie on the epistemology of assessing biosignature claims Group Presentation 4
 

Š 2006-2025 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity